Rigel Pharmaceuticals Inc (RIGL)

Sales/Maturities of Investments

$92.78M

Quarterly · Period ending: · USD

RIGL logo

RIGL Sales/Maturities of Investments

Latest reported$92.78M
RIGL Quarterly Sales/Maturities of Investments ($3.97M → $92.78M)
High-resolution chart · PNG

RIGL sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
0
3,965,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.